Bad medicine

Lessons from those who are succeeding at stamping out the toxic but persistent problem of substandard medicines

(more…)

Fraudulent and substandard antimalarials drive up case numbers, suffering and death. They are the main obstacle as India pursues malaria eradication by 2030.

(more…)

Buying medicines on the internet saves time and money, but it could be deadly. Indonesia is working to regulate online pharmacies and improve public safety.

(more…)

The rampant trade in fake sexual stimulants is a reminder of how easy it is for substandard medicines to take hold and the need for greater public awareness.

(more…)

The best form of inspection is an unannounced one, but the pandemic changed the game for regulators. They’ll need to work together to protect consumers.

(more…)

COVID-19 has shown that regulatory processes can fail anywhere, allowing poor-quality medicines through. A new detection test could help shield consumers.

(more…)

Australia is reliant on imports for the majority of its medicines – in this age of global epidemics regulatory vigilance has never been more important.

(more…)

The key ingredient in detecting a counterfeit medicine could be in your kitchen.

(more…)

Poverty drives the market in inferior medicines just as it drives other examples of inequality. A socially integrated approach is needed to fight the problem.

(more…)

India’s booming biopharma sector presents a new challenge for regulators.

(more…)